Clinical Trials Directory

Trials / Completed

CompletedNCT01235533

Fish Oil Supplementation in Late-life Depression

The Assessment for the Effects of Health Products on Depression and Cognitive Function:Fish Oil in Patients With Late-life Depression

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
89 (actual)
Sponsor
Taipei City Psychiatric Center, Taiwan · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

To investigate whether fish oil supplementation, compared to placebo (olive oil), could have better effects on depression course and cognitive function in older people with major depression.

Detailed description

Patients with late-life depression were reported cognitive impairment, especially in information-processing speed, working memory, attention and episodic memory, even after depressive symptoms subside and some of them further progress to dementia in two to four years. Several epidemiological studies, fatty acid comparison studies, animal studies, and clinical trials found that omega-3 polyunsaturated fatty acids (PUFAs) were significantly associated with the major depression, cognitive decline in general population and Alzheimer's disease. Until now, there is no study investigating the effects of n-3 PUFAs on depressive symptoms and cognition in patients with late-life depression. Thus, the aims of this study were to investigate whether fish oil supplementation, compared to placebo (olive oil), could have better effects on depression course and cognitive function in older people with major depression.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTN-3 polyunsaturated fatty acidsThree capsules per day. Each capsule included 600mg eicosapentanoic acid (20:5n-3), 400 mg of docosahexanoic acid (22:6n-3), tertiary-butylhydroquinone 0.2 mg/g and tocopherols 2 mg/g.

Timeline

Start date
2007-05-01
Primary completion
2010-09-01
Completion
2010-09-01
First posted
2010-11-05
Last updated
2010-11-05

Locations

2 sites across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01235533. Inclusion in this directory is not an endorsement.